Clinical Trials

Showing 441 - 460 of 494 trials
Title Investigatorsort icon Disease(s)
A Phase II Study of 5'-Azacitidine to Prevent Recurrence in Patients Who Had a Donated Stem Cell Transplant for Acute Myeloid Leukemia or Myelodysplastic Syndromes
[Protocol 13-192]
Tamari, Roni
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
A Phase Ib/II Study of Gemcitabine and Docetaxel Plus Pazopanib for the Neoadjuvant (Presurgical) Treatment of Soft-Tissue Sarcoma
[Protocol 11-104]
Tap, William
  • Sarcomas
    • Soft Tissue Sarcoma
A Phase III Study of Doxorubicin Alone or in Combination with TH-302 in Patients with Locally Advanced Inoperable or Metastatic Soft-Tissue Sarcoma
[Protocol 11-203]
Tap, William
  • Sarcomas
    • Soft Tissue Sarcoma
A Phase I Study of PLX3397 in Patients with Advanced Solid Tumors
[Protocol 12-156]
Tap, William
  • Sarcomas
    • Soft Tissue Sarcoma
  • Thyroid Cancer
Geriatric Assessment and Nursing Telephone Intervention in Elderly Women with Ovarian Cancer
[Protocol 11-164]
Tew, William
  • Geriatrics
  • Ovarian Cancer
Clinical and Biological Predictors of Chemotherapy Toxicity in Older Adults
[Protocol 12-089]
Tew, William
  • Breast Cancer
  • Geriatrics
Chemotherapy Toxicity in Elderly Women with Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
[Protocol 12-104]
Tew, William
  • Geriatrics
  • Ovarian Cancer
Prospective Ascertainment for Late Effects Among Cancer Survivors
[Protocol 12-143]
Tonorezos, Emily
  • Survivorship
A Phase II Study of Dose-Dense Doxorubicin and Cyclophosphamide followed by Eribulin Mesylate for the Adjuvant Treatment of Early-Stage Breast Cancer
[Protocol 10-190]
Traina, Tiffany
  • Breast Cancer
A Phase II Study of Exemestane with and without Enzalutamide in Women with Advanced Hormone Receptor-Positive Breast Cancer
[Protocol 13-257]
Traina, Tiffany
  • Breast Cancer
A Phase I Study of Enzalutamide (MDV3100) in Patients with Previously Treated Metastatic Breast Cancer
[Protocol 12-155]
Traina, Tiffany
  • Breast Cancer
A Phase II Study of Enzalutamide in Women with Triple-Negative Breast Cancer that Contains the Androgen Receptor
[Protocol 13-158]
Traina, Tiffany
  • Breast Cancer
A Phase I/II Study of Brentuximab (SGN-35) in Pediatric Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma or Hodgkin Lymphoma
Relapsed/Refractory
[Protocol 11-210]
Trippett, Tanya
  • Lymphoma
    • Hodgkin's Disease
    • Non-Hodgkin's Lymphoma
A Phase I Study of Cabazitaxel in Children and Teens with Persistent Solid Tumors
Relapsed/Refractory
[Protocol 13-021]
Trippett, Tanya
  • Pediatric Brain Tumors
    • CNS Cancer
  • Primary Bone
  • Sarcomas
  • Solid Tumors
A Phase I Study of SGN-CD19A in Children and Adults with Persistent B-Cell Acute Lymphoblastic Leukemia or Aggressive Non-Hodgkin Lymphoma
Relapsed/Refractory
[Protocol 13-106]
Trippett, Tanya
  • Leukemia
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II Study of Cyclophosphamide, Topotecan, and Bevacizumab in Patients with Relapsed or Refractory Ewing's Sarcoma and Neuroblastoma
Newly Diagnosed & Relapsed/Refractory
[Protocol 11-183]
Trippett, Tanya
  • Neuroblastoma
  • Primary Bone
    • Ewing's Sarcoma
  • Sarcomas
    • Ewing's Sarcoma
    • Soft Tissue Sarcoma
A Phase I/II Clinical Study of Vorinostat Plus Etoposide in Pediatric Patients with Refractory Solid Tumors
[Protocol 10-096]
Trippett, Tanya
Impact of Breast Conservation Surgery on Surgical Outcomes and Cosmetic Appearance in Patients with Multiple Tumors in One Breast
[Protocol 13-023]
Van Zee, Kimberly
  • Breast Cancer
A Phase I Study of VS-5584 in Patients with Lymphoma or Advanced Solid Tumors
[Protocol 14-065]
Varghese, Anna
  • Lymphoma
  • Solid Tumors
A Phase I Study of LY3023414 in Patients with Advanced Cancer
[Protocol 12-286]
Varghese, Anna
  • Solid Tumors